A Euphoria-Suppressing Opioid, Ketan Mehta, Founder & CEO, Tris Pharma

episode

BioTech Nation ... with Dr. Moira Gunn not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

How to Manifest What You Desire 20 min · 18 Sep 2026 · The Mindset Mentor

The latest on AI panic — and whether it's justified 17 min · 18 Sep 2026 · Short Wave

Big mysteries explained through your senses 54 min · 18 Sep 2026 · TED Radio Hour

Secret Life of the Pre-Raphaelite Brotherhood 30 min · 18 Sep 2026 · Secret Life of Books

Report any issue

Source

Recorded11 Jan 2026

Publisherfeeds.transistor.fm ↗

Handlerec:15253116

Show notes

This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. On this episode of BioTech Nation...Ever wonder what makes opioids so addictive? Moira speaks with Ketan Mehta, Founder and CEO of Tris Pharma, about opioid-induced euphoria...and an opioid that's actually meant to suppress this response. For more information about BioTech Nation and the companies featured here, visit: TechNation.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in